Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
China
· Delayed Price · Currency is CNY 21.29
+0.48 (2.31%)
Mar 10, 2026, 11:29 AM CST
SHA:688687 Revenue
Beijing Kawin Technology Share-Holding had revenue of 360.40M CNY in the quarter ending September 30, 2025, a decrease of -12.95%. This brings the company's revenue in the last twelve months to 1.15B, down -21.13% year-over-year. In the year 2024, Beijing Kawin Technology Share-Holding had annual revenue of 1.23B, down -12.87%.
Revenue (ttm)
1.15B
Revenue Growth
-21.13%
P/S Ratio
3.04
Revenue / Employee
1.91M
Employees
600
Market Cap
3.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.23B | -181.71M | -12.87% |
| Dec 31, 2023 | 1.41B | 252.03M | 21.73% |
| Dec 31, 2022 | 1.16B | 15.62M | 1.36% |
| Dec 31, 2021 | 1.14B | 282.30M | 32.75% |
| Dec 31, 2020 | 862.05M | 37.13M | 4.50% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yantai Zhenghai Biotechnology | 347.60M |
| Shanghai Model Organisms Center | 421.26M |
| Shanghai Shen Lian Biomedical | 288.27M |
| Guangdong VTR Bio-Tech | 830.87M |
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Cabio Biotech (Wuhan) | 574.88M |
| Boji Medical Technology | 770.19M |
| Qingdao Vland Biotech INC. | 1.39B |